Elizabeth Jobes
Compliance Officer at IMMUNOCORE HOLDINGS PLC
Net worth: 183 412 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Nesci | M | 51 |
Blue Foundry Bank
 Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 6 years |
| Rory Nealon | M | 56 | 5 years | |
| Wilfred A. Jefferies | M | 65 |
Eyam Vaccines & Immunotherapeutics Ltd.
| - |
| Jonathan M. Shaw | M | 58 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 14 years |
| John Bell | M | 71 | 9 years | |
| Joe Wiley | M | 53 | 5 years | |
| Margaret Letsche | F | 71 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 9 years |
| Mirella Lang | F | 45 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 4 years |
| Michael Martino | M | 68 | 3 years | |
| J. Buchi | M | 69 | 3 years | |
| Patrick H. Kinzler | M | 65 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 12 years |
| Robert T. Goldstein | M | 61 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 9 years |
| J. Christopher Ely | M | 67 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 19 years |
| Kenneth Grimbilas | M | 70 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 13 years |
| Elyse Beidner | F | 70 | 20 years | |
| Roy Herbst | M | 60 | 3 years | |
| Kelly Pecoraro | F | 55 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 2 years |
| Suketu Upadhyay | M | 55 | 9 years | |
| Alex Malkiman | M | 49 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 2 years |
| Travis Coy | M | 43 | 5 years | |
| Elizabeth Miller | F | 64 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 6 years |
| Ray Stafford | M | 77 | 8 years | |
| Kristine Peterson | F | 64 | 7 years | |
| Thomas Packwood | M | 58 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 13 years |
| Stephen Joyce | M | - | - | |
| Acela Roselle | F | 63 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 25 years |
| Sheila Frame | F | 62 | - | |
| Robert Perez | M | 59 | 5 years | |
| David Stevens | M | 75 | 13 years | |
| Ryan M. Thomas | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 4 years |
| Jason Goldberg | M | 49 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 3 years |
| Caroline B. Manogue | F | 55 | 9 years | |
| Bahija Jallal | M | 62 | 5 years | |
| Peter Ratcliffe | M | 69 | 4 years | |
| Lily Hepworth | F | - | 6 years | |
| Ailish Hogan | F | - | - | |
| Tracy Cunningham | M | - | 4 years | |
| Mugur Tolea | M | 56 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 3 years |
| Siddharth Kaul | M | 63 | 2 years | |
| Michele Dowling Johnson | F | 57 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 4 years |
| Pamela Lincez | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 3 years |
| Roslyn Ritchie-Derrien | F | 61 |
Eyam Vaccines & Immunotherapeutics Ltd.
| 4 years |
| Ralph Torbay | M | - | 3 years | |
| John Trainer | M | 50 | 1 years | |
| Helen Phillips | M | - | - | |
| Stephen Wills | M | 67 | 5 years | |
| Julie Eastwood | F | - | 5 years | |
| Lyle Oberg | M | 63 |
Eyam Vaccines & Immunotherapeutics Ltd.
| - |
| Terry Pearson | M | 78 |
Eyam Vaccines & Immunotherapeutics Ltd.
| 2 years |
| Daniel Rudio | M | 50 | 9 years | |
| Brian DiDonato | M | 57 | 4 years | |
| Robert Rowe | M | 62 | 2 years | |
| Alain Munoz | M | 75 | 5 years | |
| Patrick Volkert Vink | M | 60 | 5 years | |
| Theo Warkentin | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 4 years |
| Rajiv De Silva | M | 58 | 9 years | |
| Roni Mamluk | M | 57 | 3 years | |
| Laurence S. Smith | M | - | 9 years | |
| John McEvoy | M | 37 | 7 years | |
| Karen A. Wallace | F | 57 | 9 years | |
| James E. LaBelle | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 3 years |
| John Goll | M | - | 1 years | |
| Tina St. Leger | F | 56 | 2 years | |
| Donald Stern | M | 78 | 5 years | |
| George Hampton | M | 54 | 5 years | |
| Reno Pontarollo | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 4 years |
| David Berman | M | - | 5 years | |
| Mohammed Dar | M | - | 5 years | |
| Rajkumar Kannan | M | 61 | 3 years | |
| Guy T. Donatiello | M | - | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Dougherty | M | 66 |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 11 years |
| Alex Agnoletto | M | 32 |
Blue Foundry Bank
Blue Foundry Bank Savings BanksFinance Part of Blue Foundry MHC, Blue Foundry Bank operates as a state chartered savings bank. The company is based in Rutherford, NJ. James Domenick Nesci has been the CEO of the company since 2018. | 2 years |
| David Bar-Or | M | 75 | 12 years | |
| Michael E. Macaluso | M | 72 | 12 years | |
| Rolf Classon | M | 79 | 10 years | |
| Andrew Koven | M | 66 | 3 years | |
| Holli Cherevka | F | 41 | 9 years | |
| Adrian Adams | M | 73 | 4 years | |
| Richard Giles | M | 74 | 12 years | |
| John M. Limongelli | M | 54 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 3 years |
| Stephen Webster | M | 63 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 3 years |
| Peter Brandt | M | 67 | 5 years | |
| Nancy Lurker | F | 66 | 4 years | |
| Oliver Fetzer | M | 60 | 10 years | |
| Paul Friedman | M | 81 | 5 years | |
| William McKee | M | 62 | 6 years | |
| Paul Goddard | M | 74 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 11 years |
| Armando Anido | M | 66 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 8 years |
| James Fickenscher | M | 60 | 9 years | |
| Georges Gemayel | M | 63 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 4 years |
| Philip Coelho | M | 80 | 12 years | |
| David Michael Madden | M | 61 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 11 years |
| Keri Mattox | F | - | - | |
| Jennifer Lou Armstrong-Owen | F | 54 | 6 years | |
| Lisa Buffington | F | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 5 years |
| Eric Trachtenberg | M | 51 | 3 years | |
| James Tursi | M | 59 | 6 years | |
| Andrew Saik | M | 54 | 1 years | |
| Anthony Blandin | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 59 | 59.60% |
| United Kingdom | 16 | 16.16% |
| Ireland | 15 | 15.15% |
| Canada | 9 | 9.09% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Elizabeth Jobes
- Personal Network
